Assessment of Inflammatory Mediators (AIM)

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 31, 2004

Study Completion Date

March 31, 2006

Conditions
Cystic Fibrosis
Interventions
DRUG

Ibuprofen

Trial Locations (16)

21287

Johns Hopkins Hospital, Baltimore

27599

University of North Carolina, Chapel Hill, Chapel Hill

35223

University of Alabama at Birmingham, Birmingham

44106

Case Western Reserve University - Rainbow Babies and Children's Hospital, Cleveland

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

52242

University of Iowa, Iowa City

55455

University Of Minnesota, Minneapolis

63110

Washington University - St. Louis Children's Hospital, St Louis

77030

Baylor College of Medicine - Texas Children's Hospital, Houston

80218

University of Colorado Health Sciences Center - Children's Hospital, Denver

84132

University of Utah Health Sciences Center, Salt Lake City

92123

University of California - San Diego, San Diego

94304

Stanford University - Packard Children's Hospital, Palo Alto

02114

Massachusetts General Hospital, Boston

02115

Harvard University - Children's Hospital of Boston, Pulmonary Division, Boston

43205-2696

Columbus Children's Hospital, Columbus

All Listed Sponsors
collaborator

Cystic Fibrosis Foundation

OTHER

lead

Ramsey, Bonnie, MD

INDIV

NCT00219895 - Assessment of Inflammatory Mediators (AIM) | Biotech Hunter | Biotech Hunter